New Zealand markets closed

NatureWise Biotech & Medicals Corporation (4732.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
25.25-0.70 (-2.70%)
At close: 02:53PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
292,795
160,142
228,590
249,801
306,919
-
Cost of revenue
122,292
72,763
98,663
103,616
123,484
-
Gross profit
170,503
87,379
129,927
146,185
183,435
-
Operating expenses
Research development
60,625
30,007
49,481
69,457
68,135
-
Selling general and administrative
51,636
53,941
54,064
49,751
57,394
-
Total operating expenses
112,261
83,948
103,545
119,208
125,529
-
Operating income or loss
58,242
3,431
26,382
26,977
57,906
-
Interest expense
39
52
40
32
58
-
Income before tax
62,363
9,924
30,024
30,640
59,333
-
Income tax expense
-168
-196
0
-168
-5,983
-
Income from continuing operations
62,531
10,120
30,024
30,808
65,316
-
Net income
62,531
10,120
30,024
30,808
65,316
-
Net income available to common shareholders
62,531
10,120
30,024
30,808
65,316
-
Basic EPS
0.33
-
0.61
0.63
1.33
1.05
Diluted EPS
0.33
-
0.61
0.62
1.32
1.05
Basic average shares
49,290
-
49,290
49,290
49,290
37,802
Diluted average shares
49,796
-
49,485
49,336
49,362
37,802